Researchers to test whether young blood plasma can treat Alzheimer's

08/21/2014 | New Scientist · Gizmodo

A clinical trial will study the effect of blood plasma transfusions from people younger than 30 on patients with mild to moderate Alzheimer's disease. The study will start in October at the Stanford University School of Medicine. A protein in blood plasma called growth differentiation factor 11, or GDF11, declines with age, and it has been linked with improved brain function in animal studies.

View Full Article in:

New Scientist · Gizmodo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC